112 related articles for article (PubMed ID: 38518655)
1. Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy.
Singh KP; Avihingsanon A; Zerbato JM; Zhao W; Braat S; Tennakoon S; Rhodes A; Matthews GV; Fairley CK; Sasadeusz J; Crane M; Audsley J; Lewin SR
EBioMedicine; 2024 Apr; 102():105054. PubMed ID: 38518655
[TBL] [Abstract][Full Text] [Related]
2. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G;
Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504
[TBL] [Abstract][Full Text] [Related]
3. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.
Boyd A; Bottero J; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Serfaty L; Lacombe K
J Int AIDS Soc; 2017 Feb; 20(1):21426. PubMed ID: 28362068
[TBL] [Abstract][Full Text] [Related]
4. Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBV.
Grant JL; Agaba P; Ugoagwu P; Muazu A; Okpokwu J; Akpa S; Machenry S; Imade G; Agbaji O; Thio CL; Murphy R; Hawkins C
J Antimicrob Chemother; 2019 Jul; 74(7):2003-2008. PubMed ID: 31225612
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
[TBL] [Abstract][Full Text] [Related]
6. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection.
Singh KP; Zerbato JM; Zhao W; Braat S; Deleage C; Tennakoon GS; Mason H; Dantanarayana A; Rhodes A; Rhodes JW; Torresi J; Harman AN; Revill PA; Crane M; Estes JD; Avihingsanon A; Lewin SR; Audsley J
PLoS Pathog; 2020 Sep; 16(9):e1008744. PubMed ID: 32898182
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection.
Malagnino V; Bottero J; Miailhes P; Lascoux-Combe C; Girard PM; Zoulim F; Lacombe K; Boyd A
J Med Virol; 2019 Apr; 91(4):630-641. PubMed ID: 30431661
[TBL] [Abstract][Full Text] [Related]
9. HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.
Maponga TG; Andersson MI; van Rensburg CJ; Arends JE; Taljaard J; Preiser W; Glashoff RH
BMC Infect Dis; 2018 May; 18(1):214. PubMed ID: 29739341
[TBL] [Abstract][Full Text] [Related]
10. Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis B Virus-Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort.
Dezanet LNC; Kassime R; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A
Clin Infect Dis; 2022 Mar; 74(6):1012-1021. PubMed ID: 34197574
[TBL] [Abstract][Full Text] [Related]
11. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.
Cooper C; Rollet-Kurhajec KC; Young J; Vasquez C; Tyndall M; Gill J; Pick N; Walmsley S; Klein MB;
HIV Med; 2015 Jan; 16(1):24-31. PubMed ID: 24837567
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
[TBL] [Abstract][Full Text] [Related]
13. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.
Ding Y; Duan S; Ye R; Yang Y; Yao S; Wang J; Cao D; Liu X; Lu L; Jia M; Wu Z; He N
J Viral Hepat; 2017 May; 24(5):412-420. PubMed ID: 27925409
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
van Griensven J; Phirum L; Choun K; Thai S; De Weggheleire A; Lynen L
PLoS One; 2014; 9(2):e88552. PubMed ID: 24533106
[TBL] [Abstract][Full Text] [Related]
15. Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up.
Calin R; Guiguet M; Desire N; Imbert-Bismut F; Munteanu M; Poynard T; Valantin MA; Stitou H; Katlama C; Thibault V
J Clin Virol; 2013 Oct; 58(2):408-14. PubMed ID: 23958588
[TBL] [Abstract][Full Text] [Related]
16. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
[TBL] [Abstract][Full Text] [Related]
17. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
[TBL] [Abstract][Full Text] [Related]
18. HBV co-infection is associated with persistently elevated liver stiffness measurement in HIV-positive adults: A 6-year single-centre cohort study in Nigeria.
Rivera AS; Machenry S; Okpokwu J; Olatunde B; Ugoagwu P; Auwal M; Sule H; Agaba P; Agbaji OO; Thio CL; Murphy RL; Hawkins C
Antivir Ther; 2021 Nov; 26(6-8):106-116. PubMed ID: 35485338
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia.
Muula GK; Bosomprah S; Sinkala E; Nsokolo B; Musonda T; Hamusonde K; Bhattacharya D; Lauer G; Chung RT; Mulenga LB; Wandeler G; Vinikoor MJ
AIDS; 2023 Nov; 37(13):2015-2020. PubMed ID: 37467044
[TBL] [Abstract][Full Text] [Related]
20. HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.
Zerbato JM; Avihingsanon A; Singh KP; Zhao W; Deleage C; Rosen E; Cottrell ML; Rhodes A; Dantanarayana A; Tumpach C; Tennakoon S; Crane M; Price DJ; Braat S; Mason H; Roche M; Kashuba ADM; Revill PA; Audsley J; Lewin SR
EBioMedicine; 2023 Jan; 87():104391. PubMed ID: 36502576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
